To enable the development of a tandem mass spectrometry (MS/MS) based methodology for selective protein identification and differential quantitative analysis, a novel derivatization strategy is proposed, based on the formation of a "fixed-charge" sulfonium ion on the side-chain of a methionine amino acid residue contained within a protein or peptide of interest. The gas-phase fragmentation behavior of these side chain fixed charge sulfonium ion containing peptides is observed to result in exclusive loss of the derivatized side chain and the formation of a single characteristic product ion, independently of charge state or amino acid composition. Thus, fixed charge containing peptide ions may be selectively identified from complex mixtures, for example, by selective neutral loss scan mode MS/MS methods. Further structural interrogation of identified peptide ions may be achieved by subjecting the characteristic MS/MS product ion to multistage MS/MS (MS 3 ) in a quadrupole ion trap mass spectrometer, or by energy resolved "pseudo" MS 3 in a triple quadrupole mass spectrometer. The general principles underlying this fixed charge derivatization approach are demonstrated here by MS/MS, MS 3 and "pseudo" MS 3 analysis of side chain fixed-charge sulfonium ion derivatives of peptides containing methionine formed by reaction with phenacylbromide. Incorporation of "light" and "heavy" isotopically encoded labels into the fixed-charge derivatives facilitates the application of this method to the quantitative analysis of differential protein expression, via measurement of the relative abundances of the neutral loss product ions generated by dissociation of the light and heavy labeled peptide ions. This approach, termed "selective extraction of labeled entities by charge derivatization and tandem mass spectrometry" (SELECT), thereby offers the potential for significantly improved sensitivity and selectivity for the identification and quantitative analysis of peptides or proteins containing selected structural features, without requirement for extensive fractionation or otherwise enrichment from a complex mixture prior to analysis. (J Am Soc Mass Spectrom 2005, 16, 1131-1150
P roteomic studies involving the comprehensive identification, characterization, and quantitative analysis of all the gene products, i.e., proteins expressed by a particular cell or tissue type at a given time, together with the systematic characterization of their specific functional interactions, have recently emerged as a means to determine the hitherto unknown functional role of the thousands of genes identified from recent genome sequencing initiatives [1, 2] . It is widely anticipated that one of the major outcomes of these studies will be a more complete understanding of the processes that control cellular biochemistry, as well as allowing the development of novel therapeutic agents targeted toward specific biomarkers of disease. Substantial progress in the field has been achieved in recent years, primarily via the application of mass spectrometry (MS) instrumentation and associated sample handling methodologies, together with the development of sophisticated bioinformatic tools, for rapid protein identification and characterization [3] . However, there are a number of issues that currently limit the ability of these mass spectrometry based approaches to translate the "promise" of proteomics into "practice". Foremost among these is the significant analytical chal-lenge presented by the mixture complexity, dynamic range and diversity of transcriptional, translation, and post translational modifications associated with the proteome, which is in a constant state of spatial and temporal flux throughout the cell cycle.
Mass Spectrometry (MS) Methods for Selective Protein Identification and Quantitative Analysis
In a typical approach to protein identification and characterization, complex protein mixtures or individual proteins resolved by electrophoretic or chromatographic methods are subjected to proteolysis, and the resultant peptide mixtures then introduced to the mass spectrometer by on-line chromatography. Following determination of their masses, individual peptide ions are then selected for sequence analysis by tandem mass spectrometry (MS/MS) [4] . Subsequently, protein identification may be achieved by database analysis of the uninterrupted product ion spectrum [5] , by database searching of a partially derived amino acid "sequence tag" [6] , or by "de-novo" sequence analysis [4] . A major limitation of this analysis strategy however, is that proteolytic digestion increases the complexity of the component mixture by up to several orders of magnitude, thereby placing significant demands on the performance of the analytical methodologies employed for peptide separation and analysis. Furthermore, although affinity purification [7] and off-and on-line multidimensional chromatographic [8] approaches have been developed for simplification of these complex peptide mixtures prior to MS, and dynamic exclusion methods [9, 10] have been developed to allow greater numbers of distinct peptide ions to be selected for MS/MS analysis, information regarding the identity of proteins represented as low abundance peptides is commonly not obtained, thereby limiting the dynamic range [11] .
Issues associated with mixture complexity and dynamic range also present a challenge to the application of mass spectrometry to the quantitative analysis of protein abundances observed between two different states of a biological system, such as that encountered between normal versus diseased cells. To date, the majority of these methods have employed either in vivo metabolic labeling [12] [13] [14] or in vitro chemical derivatization [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] to introduce a characteristic differential isotopic mass "tag" between two different samples of interest. The samples are then combined and the proteins subjected to proteolysis (this order may be reversed if differential labeling occurs during or following the proteolytic digestion step), and the masses of the resultant peptides determined by MS. By comparing the relative abundances of peptide ions originating from an isotopically enriched sample with those originating from a sample prepared using naturally abundant isotopes, quantitation of differences in protein abundance between the two samples may be obtained. All these methods for quantitation, however, have been based on a common approach for identification of the differential mass "signature" between the two samples, i.e., by mass analysis of their intact peptide precursor ions.
Limitations to this general analysis strategy may be encountered, therefore, when (1) separation of the differentially labeled "light" and "heavy" peptides occurs during chromatographic fractionation of the peptide mixture [35, 36] , (2) the m/z values of differentially labeled peptide ions overlap with nonlabeled peptide components present in the mixture, or (3) one or both of the differentially labeled peptide ions of interest are present at, or below, the limit of detection of the mass spectrometer [37] . The use of 13 C instead of 2 H labeling has been employed to eliminate the deuterium isotope effect responsible for the first of these limitations [33] . The second limitation has been at least partially addressed by the application of strategies for selective enrichment of labeled peptides prior to MS analysis, via affinity purification [15] or solid phase capture [34] , or by methods for extensive multidimensional chromatographic fractionation of peptide mixtures prior to analysis [38, 39] . To date, however, limitations associated with the detection of low abundance differentially labeled peptide ions via conventional MS based methods have proven difficult to address.
Tandem Mass Spectrometry (MS/MS) Methods for Selective Protein Identification and Quantitative Analysis
Recently, an MS/MS based "tandem mass tag" approach for differential quantitative protein analysis has been described that holds promise in addressing this problem [40] . This method is based on measurement of the relative abundances of characteristic isotopically encoded low mass product ions formed by MS/MS from N-terminally derivatized peptides. Similar approaches, employing precursor ion or neutral loss MS/MS scan modes [41] , whereby the mass spectrometer is set to detect a characteristic low mass product ion, or a characteristic product ion offset by a given mass from the selected precursor, respectively, have been extensively employed in the past for the selective identification of peptide ions containing certain structural features (e.g., particular amino acid residues [42] , post-translational modifications [43] [44] [45] [46] [47] [48] [49] , or chemical cross linking agents [50] ). Because of the reduction in chemical noise associated with the MS/MS experiment, these methods have been demonstrated to yield greater specificity and increase sensitivity by 1 to 2 orders of magnitude over conventional MS based detection methods, and to enable the detection of low abundance precursor ions that may not otherwise be apparent in the MS experiment, i.e., below the level of chemical noise [37] . One of the major limitations of all these methods, however, is that the desired fragmentation pathway giving rise to the product ion of interest is typically only one of many dissociation channels, thereby "diluting" the spectrum and limiting the dynamic range.
The reason for a desired fragmentation pathway often not yielding a dominant product ion may be rationalized by taking into consideration the generally accepted mechanisms and other factors (such as peptide ion charge state and amino acid composition) known to be responsible for the gas-phase dissociation reactions of protonated peptide ions. Under low-energy collisional activation conditions, the cleavage of most bonds within a protonated peptide ion is thought to require localization of an ionizing proton at the cleavage site. Fragmentation then proceeds via "charge-directed" neighboring group participation mechanisms involving nucleophilic attack from an adjacent functional group [51] [52] [53] [54] . The formation of product ions resulting from "enhanced" cleavage at the N-terminal side of proline residues has been consistently noted in the literature, presumably because of the higher local proton affinity of the proline imide bond compared with a conventional amide bond. However, consistent with the idea that the strongly basic guanidino side chain of arginine residues may act to strongly "sequester" ionizing protons, thereby limiting their ability to be transferred along the peptide backbone to initiate cleavage by charge-directed pathways, a recent report has demonstrated that enhanced proline cleavage is only observed as a dominant process under conditions where the number of ionizing protons is greater than the number of arginine residues contained within the peptide ion [55] . Indeed, under conditions where the number of ionizing protons is less than or equal to the number of arginine residues within the peptide ion, enhanced cleavages at other sites along the peptide backbone via "charge-remote" mechanisms, for example at the Cterminal side of aspartic acid residues or at the side chains of methionine sulfoxide residues, are commonly observed [55, 56] .
The derivatization reagent employed in the "tandem mass tag" strategy described above contains a fragmentation "enhancement" group consisting of a proline residue to promote cleavage within the label during MS/MS, as well as a "sensitization" group containing a guanidino group to promote formation of a characteristic protonated low mass product ion following the fragmentation reaction [40] . However, the presence of the guanidino "sensitization" group may actually act to limit proton mobility, and thereby hinder the desired fragmentation pathway from proceeding. Therefore, the formation of abundant low mass product ions characteristic of "tandem mass tag" derivatized peptides are only expected for a sub-set of the total peptide ions presented to the mass spectrometer for dissociation.
Here, to address this problem and to facilitate the development of a general MS/MS based approach for selective protein identification and differential quantitative analysis, we propose a novel derivatization strategy, termed selective extraction of labeled entities by charge derivatization and tandem mass spectrometry (SELECT), that is based on the formation of a "fixedcharge" on the side-chain of a selected amino acid residue contained within a protein or peptide of interest. Although fixed charge derivatization strategies for peptides have been used previously in conjunction with MS/MS for sequencing applications, most prior work has been limited to derivatization of the N-and Ctermini, as well as lysine and arginine side chains, and has been focused on directing fragmentation toward the formation of a particular series of backbone cleavage derived sequence ions (i.e., maximizing sequence coverage) [57] [58] [59] [60] [61] [62] . In contrast, the MS/MS dissociation of peptide ions containing the fixed charge derivatives described here are directed toward the exclusive formation of a single characteristic side chain product ion, independently of the amino acid composition, proton mobility, or precursor ion charge state. These fixed charge containing peptide ions may therefore be readily identified from complex mixtures, for example, by selective neutral loss scan mode MS/MS methods. Further structural interrogation of peptide ions identified by the fixed charge derivatization approach may be achieved by subjecting the characteristic MS/MS product ion to multistage MS/MS (MS 3 ) in a quadrupole ion trap mass spectrometer, or by energy resolved "pseudo" MS 3 in a triple quadrupole mass spectrometer. Incorporation of "light" and "heavy" isotopically encoded labels into the fixed-charge derivatives also facilitates the application of this MS/MS method to the quantitative analysis of differential protein expression. The SELECT fixed-charge derivatization approach thereby offers the potential for significantly improved sensitivity and selectivity for the identification and quantitative analysis of peptides or proteins containing certain structural features, without the requirement for extensive fractionation or otherwise enrichment from a complex mixture prior to analysis.
Materials and Methods

Materials
The synthetic peptides GAILMGAILA, GAILMGAILK, GAILMGAILR, VTMGHFCNFGK, and VTMGHFDN-FGR were purchased from Auspep (Melbourne, Australia). Iodomethane, iodoethane, iodobenzene, iodomethylbenzene, d 5 -acetophenone, and poly(4-vinylpyridinium tribromide) were obtained from Aldrich (Castle Hill, Australia). Phenacylbromide was purchased from Fluka (Castle Hill, Australia). Iodoacetic acid and iodoacetamide were from Sigma (St. Louis, MI). Methanol, and acetonitrile (Chromar grade) were purchased from Mallinkrodt (Paris, KY). Acetic acid was obtained from BDH Laboratories (Poole, United Kingdom). All solutions were prepared using deionized water purified by a tandem Milli-Q and Milli-RO system (Millipore, Bedford, MA). Unless stated otherwise, all reagents were AR grade and used as supplied without further purification.
Synthesis of 2=,3=,4=,5=,6=-2 H 5 -Phenacylbromide
2=,3=,4=,5=,6=-2 H 5 -phenacylbromide was synthesized according to the method of Frechet et al. [63] °Briefly, 2=,3=,4=,5=,6=-2 H 5 -acetophenone (1 mmol, 1.25 mL) was added to poly(4-vinylpyridinium tribromide) (4.8 g , ϳ3 meq Br 3 Ϫ /g resin) in 30 mL methanol, then allowed to react with stirring at room temperature for 4 h. The resultant ␣-bromo ketone was obtained in pure form by filtration of the reaction mixture, followed by evaporation of the solvent and recrystallization prior to use.
Side Chain Fixed-Charge Derivatization of Methionine-Containing Peptides
Side chain fixed-charge sulfonium ion derivatives of synthetic methionine-containing model "tryptic" peptides were produced by the addition of 10 L of a 1M solution of alkylating reagent to 100 g of peptide dissolved in 100 L of aqueous 20% HOAc containing 30% CH 3 CN. The reaction was allowed to proceed for 24 h at room temperature after which the sample was diluted then introduced to the mass spectrometer with no further purification.
Mass Spectrometry
Mass spectrometric analysis was performed using (1) 
Quadrupole Ion Trap Mass Spectrometry
Samples (10 pmol/L in 50:50:1 H 2 O/CH 3 CN/HOAc) were introduced to the mass spectrometer by electrospray ionization at 2 L/min. ESI conditions were optimized to maximize the intensity of the ion of interest and to minimize the extent of "in-source" fragmentation. Typical conditions were: spray voltage Ϫ5 kV, nitrogen sheath gas, 30 psi, heated capillary temperature 150°C. MS/MS and MS 3 experiments were performed on mass selected ions using standard isolation and excitation procedures. All spectra shown were the average of 10 scans.
Quadrupole-Time-Of-Flight Mass Spectrometry
Samples (10 pmol/L in 50:50:1 H 2 O/CH 3 CN/ HOAc) were introduced to the mass spectrometer by electrospray ionization at 1 L/min. Electrospray interface conditions were optimized to maximize the intensity of the ion of interest. Typical conditions were: spray voltage, Ϫ4.5 kV; nitrogen source gas, 1 psi; cone gas, 100 (arbitrary units); source temperature, 50°C; desolvation temperature, 150°C; cone voltage, 50 V (for singly charged ions), 30 V (for doubly charged ions), and 20 V (for triply charged ions). Energy resolved CID MS/MS experiments were acquired using argon as the inert collision gas at a pressure of 10 psi. The collision energy was ramped from 4 to 58 V in 1 V increments for singly charged ions, from 4 to 20 V in 1 V increments for doubly charged ions, and from 20 to 46 V in 2 V increments for triply charged ions. Spectra were acquired using the V-optics mode of the time-of-flight mass analyzer. Spectra obtained at each collision energy value were the average of 10 scans.
Triple Quadrupole Mass Spectrometry
Samples ( 
Results and Discussion
The general principles underlying the SELECT side chain fixed charge derivatization approach for protein identification and differential quantitation are demonstrated here by MS/MS and MS 3 analysis of fixedcharge sulfonium ion derivatives of peptides containing methionine. Analysis of release 45.2 of the SWISS-PROT database indicates that while the occurrence of methionine residues in the database is only 2.37%, 96.9% of the individual protein entries within the database contain at least one methionine residue, thereby satisfying the criteria that approaches for selective protein identification and quantitative analysis should minimize the number of peptides to be identified, while providing comprehensive proteome coverage.
Identification of methionine-containing peptides via CID MS/MS of their sulfonium ion fixed-charge derivatives is attractive for several reasons The chemistry and biological applications of sulfonium ions are well documented°[64° -78] .°The°alkylation°of°methionine°res-idues in proteins and peptides is specific at low pH regardless of the alkylating reagent used, because the rate of alkylation of the thioether sulfur atom of the methionine side chain is virtually independent of pH (even°down°to°pH1)° [65,°66] .°In°contrast,°the°reactivity of all other nucleophilic functional groups (e.g., cysteine, lysine and histidine residues) decreases at low pH because of the protonation. In a previous experiment aimed at elucidating the gas-phase fragmentation reactions of protonated amino acids by MS/MS, fixedcharge side chain sulfonium ion derivatives of methionine and S-methyl cysteine were observed to fragment exclusively via neutral loss of the side chain CH 3 SR 1 , where R 1°w as°a°substituted°alkyl°group°[79,°80]°(Scheme 1). This loss has also been observed previously for peptides° [81] °and°proteins° [82] .
Solution and Gas-Phase Requirements for FixedCharge Sulfonium Ion Derivatization of Methionine Containing Peptides
In order for the fixed charge derivatization strategy to be successful, both the solution-phase reactivity and the gas-phase ion chemistry of the resultant sulfonium ions must be considered. The requirements for sulfonium ion formation in solution include (1) that reactions should be easy to perform using readily available alkylating reagents, (2) that the derivatization reaction should be specific to the desired amino acid residue and proceed to completion, and (3) that the resultant sulfonium°ion°be°chemically°and°thermally°stable° [65,°83,°84] . Many of the potentially useful reagents of interest are commercially available. Others may be synthesized from commercially available precursors by using simple methods described in the literature. For example, stable isotope labeled 2=,3=,4=,5=,6=-2 H 5 -phenacylbromide may be readily prepared from 2=,3=,4=,5=,6=-2 H 5 -acetophenone in a one-step process as outlined in the Materials and Methods section above.
The reactivity and stability of a range of potential alkylating reagents for methionine side chain fixedcharge sulfonium ion formation, including iodomethane, iodoethane, iodobenzene, iodomethylbenzene, iodoacetic acid, iodoacetamide, and phenacylbromide have been evaluated by reaction with the model peptide GAILMGAILK. The peptide was reacted with a 100-fold molar excess of each alkylating reagent for 4, 8, 16, or 32 h before being analyzed by mass spectrometry to determine the extent of reaction. After 16 h, only the phenacyl°derivative°had°reacted°to°completion° [85-°87] . The ethyl derivative was found to have the least reactivity and stability in solution (only 1% reaction after 16 h). All other reagents ranged in reactivity between these two extremes. The phenacyl sulfonium ion derivative was found to be stable in solution for several weeks without significant degradation. All the sulfonium ions examined, including those with poor reactivity in solution, were found to be sufficiently stable to allow their introduction to the mass spectrometer by electrospray ionization.
Scheme 2 Scheme 1
As free SH groups of cysteine residues have been shown to effect the reversal of the alkylation of methionine°residues° [88] ,°and°transfer°of a methyl group from a sulfonium salt to a free sulfhydryl acceptor is a well known°possible°side°reaction°[89°-91],°S-alkylation°of cysteine residues prior to methionine sulfonium ion formation may be required. However, S-alkylation of a cysteine residue to yield the derivative (ϪCHCH 2 SR 2 ) [step (i) of Scheme 2] may also result in the subsequent formation of a fixed charge sulfonium ion derivative under identical conditions to those employed for alkylation of methionine, provided that the initial S-alkyl derivative is stable to sulfonium ion formation [step (ii) in Scheme 2]. Although differentiation between sulfonium ion derivatives of methionine and stable sulfonium ion derivatives of S-alkyl cysteine residues may be readily achieved during MS/MS by using an alkyl group R 2 which is NOT a methyl group, initial cysteine alkylation conditions could also be chosen so that the S-alkyl derivative is not stable to sulfonium ion formation, thereby allowing specific derivatization of methionine containing peptides only.
A key requirement of this work is that the fixed charge derivatives dissociate to yield a single characteristic product ion via cleavage of the ␥-CH 2 -S linkage adjacent to the fixed charge upon MS/MS fragmentation (Scheme 1). Thus, side reactions such as charge migration via intramolecular proton transfer, alkyl group transfer, as well as breaking of bonds to give stable°alkyl°cations°or°alkenes°must°be°avoided° [92] [93] [94] [95] [96] [97] [98] [99] [100] .°Proton°transfer°(Scheme°3,°Pathway°1)°would°give an sulfur ylide. Although the acidity of the (CH 3 ) 3 S ϩ ion [or the proton affinity of the conjugate base (CH 3 ) 2 S(CH 2 )] is unknown, sulfur ylides may be formed in solution by deprotonating sulfonium ions with bases such as hydroxide ion (HOϪ) or alkyl lithium°reagents° [92] .°Alkyl°transfer°(Scheme°3,°Path-way 2) is not likely to be a problem since intramolecular S N 2 reactions rarely occur due to high energy transition states°(colinear°geometry)° [93] .°The°solution°phase methyl cation affinities (MCAs) of some biological sulfur°systems°have°been°studied° [94] .°Unfortunately, gas-phase MCAs are limited to experimental and theoretical°estimates°for°dimethylsulfide° [95] °and°theoretical estimates°of°some°other°sulfides° [96] .°The°bond strengths of other breaking alkyl groups appear to be unknown in both the condensed phase and the gas phase. There have, however, been several studies on the fragmentation reactions of sulfonium ions as studied by mass°spectrometry° [97] [98] [99] [100] .°Scheme°3 (Pathway°3)°is highly unlikely given that the least stable carbocation is formed (CH 3 ϩ ). Problems associated with Scheme 3 (Pathways 4 and 5) can be avoided by choosing an R group that does not yield a stable ion (e.g., avoid benzyl groups etc.) and does not form an alkene (e.g., avoid ethyl or substituted ethyl groups and higher homologues), respectively. As the phenacylbromide derivatization reagent allows these side reactions to be largely avoided, this reagent has been employed for the remaining studies described herein.
Examination of the Fragmentation Behavior of Fixed-Charge Phenacyl Sulfonium Ion Derivatives of Methionine Containing Peptides CID MS/MS and MS
3 in a quadrupole ion trap mass spectrometer. The gas-phase fragmentation behavior of the fixed charge phenacyl sulfonium ion derivatives of the methionine containing peptides, GAILMGAILX (where X is either alanine, lysine, or arginine), VTMGH-FCNFGK, VTMSHFWNFGK, and VTMGHFDNFGR have been examined by CID MS/MS in a quadrupole ion trap mass spectrometer. Illustrative of the general observations made to date regarding this fragmentation behavior°are°the°data°shown°in°Figures°1-°6°and°Figures S1-S.°Figure°1°shows°the°CID°MS/MS°product°ion spectra for the singly, doubly, and triply charged phenacyl sulfonium ion derivatives of the model "tryptic" peptide GAILMGAILK, each containing a single fixed-charge corresponding to the sulfonium ion plus 0, 1, or 2 additional protons, respectively. In each case, the overwhelmingly dominant fragmentation pathway corresponded to selective cleavage of the ␥-CH-2 -S bond at the site of the fixed-charge on the methionine side chain, resulting in the neutral loss of phenacyl methyl sulfide (166 Da, CH 3 SCH 2 COC 6 H 5 )°(labeled°in°Figure°1 as ϪCH 3 SAP). This is in marked contrast to that observed for CID MS/MS of the singly and doubly protonated ions of the unmodified GAILMGAILK peptide°(Figure°2a°and°b,°respectively),°where°the°forma-tion of a series of b-and y-type ions resulting from dissociations occurring along the peptide backbone were observed. The triply charged state of the fixed charge°sulfonium°ion°containing°peptide°(Figure°1c) was the only partial exception, where some charged side chain loss of protonated phenacyl methyl sulfide was also observed. The MS/MS product ion spectra obtained by CID MS/MS of the singly and doubly charged forms of GAILMGAILA and the singly, doubly, and triply charged forms of GALMGAILR, following phenacyl sulfonium ion formation, are contained in the supplemental material accompanying this manuscript and are available from the authors upon request. The fragmentation behavior of these ions was essentially identical to that described above for the GAILM-GAILK peptide ions. Thus, in contrast to that typically observed for the fragmentation of protonated peptide ions° [55] ,°there°does°not°appear°to°be°any°significant charge state or basic amino acid composition dependence to the fragmentation behavior of the side chain fixed charge sulfonium ion containing peptides. The specificity of sulfonium ion formation at methionine residues under low pH conditions, even in the presence of an S-alkyl cysteine amino acid, is shown°in°Figure°3a.°This°figure°shows°the°mass spectrum obtained from ESI of the synthetic peptide VTMGHFCNFGK following alkylation of the cysteine residue with iodoacetamide under basic pH conditions, then overnight reaction with phenacylbromide under acidic conditions to yield the sulfonium ion. Complete conversion of the peptide to the sulfonium ion derivative was observed, with no evidence for side reactions or additional alkylation products. CID MS/MS of the doubly and triply charged precursor ions°(Figure°3b°and°c,°respectively)°resulted°in°the exclusive loss of phenacyl methyl sulfide, indicative of selective sulfonium ion formation at the thiomethyl side chain of the methionine residue. Thus, S-carboxyamidomethyl cysteine residues are not reactive to sulfonium ion formation. Once again, the selective fragmentation behavior is in stark contrast to that observed from dissociation of the unmodified peptide°ions°(Figure°4),°where°fragmentation°occur-ring along the peptide backbone to yield b-and y-type ions was observed as the major dissociation pathway. The MS/MS product ion spectra obtained by CID MS/MS of the doubly and triply charged forms of VTMGHFDNFGR, following sulfonium ion formation by reaction with phenacylbromide, are contained in the supplemental material accompanying this manuscript and are available from the authors upon request. The fragmentation behavior of these ions were essentially identical to those described above for the VTMGHFCNFGK peptide, indicating that the potentially competing reaction involving enhanced "charge remote" fragmentation at the C-terminal side of the aspartic acid residue does not compete with the "charge directed" loss of the fixed charge on the methionine side chain. Potential mechanisms for the neutral loss of CH 3 SCH 2 COC 6 H 5 from the fixed-charge phenacyl sulfonium ion peptide derivatives are shown in Scheme 4. Pathway 1 of Scheme 4 involves direct proton transfer by an intramolecular nucleophile (Nu), such as the basic side chains of arginine or lysine, the N-terminal amino group, or a backbone amide carbonyl group, resulting in elimination of the neutral to yield a 3-amino-1-butenoic acid (vinyl glycine) amino acid derivative, with a residue mass of 83 Da. Alternatively, the fragmentation may be directed by a nucleophilic attack mechanism (Pathway 2 of Scheme 4), whereby an adjacent amide carbonyl attacks the side chain to facilitate the neutral loss. Pathway 2 of Scheme 4 shows this process occurring via nucleophilic attack by the amide carbonyl on the N-terminal side of the methionine sulfonium ion derivative, resulting in a 6-membered cyclic product. However, nucleophilic attack by the amide carbonyl on the C-terminal side of the methionine sulfonium ion derivative, resulting in a 5-membered cyclic product may also be considered. A recent MS/MS and molecular orbital study examining pathways for the loss of methanesulfenic acid from methionine sulfoxide containing peptides has indicated that both of these processes have similar transition state barriers° [56] .
Intramolecular transfer of an acidic proton present in either the precursor ion (Pathway 1), or in the product ion formed following methionine side chain cleavage (Pathway 2a or 2b) would result in "mobilization" of this proton, thereby allowing it to be involved in subsequent fragmentation reactions according to the mobile proton model developed for rationalizing the fragmentation°of°protonated°peptide°ions° [51] [52] [53] [54] [55] [56] .°Note that if the reaction proceeds via Pathway 2 of Scheme 4, the amide bond incorporated into the cyclic product would not be amenable to subsequent cleavage. However, ring opening of the cyclic product via intramolecular transfer (Pathway 2a) would yield the acyclic vinyl glycine amino acid derivative, thereby allowing subsequent fragmentation of the product ion to occur on both N-and C-terminal sides of the newly formed amino acid residue. Given that the sulfonium ion derivatized peptide ions were observed to fragment almost exclusively via the neutral loss of CH 3 SCH 2 COC 6 H 5 to form a charged product ion, a further stage of tandem mass spectrometry (MS 3 ) was employed, to generate additional structural information to allow identification of the peptide by sequence analysis, and to obtain evidence for the fragmentation mechanism. The spectra obtained following CID MS 3 of each of the neutral loss°product°ions°shown°in°Figures°1°and°3°above°are shown°in°Figures°5°and°6.°MS 3 of these ions, and indeed all the [M ϩ nH Ϫ CH 3 SAP] (nϩ1)ϩ product ions formed by neutral loss from the sulfonium ion fixed-charge peptide ions studied to date, resulted in the formation of b-and y-type products ensuing from dissociations along the peptide backbone, similar to those observed by MS/MS of the unmodified peptide [M°ϩ°nH] n°ϩ°p recursor°ions°(Figures°2°and°4).°In°most cases, cleavage of the amide bonds on either side of the proposed vinyl glycine residue formed by loss of the sulfonium ion side chain was observed following MS 3 , suggesting that the fragmenting species does contain an acyclic vinyl glycine residue, formed either by Pathway 1 of Scheme 4 or by ring opening of the cyclic product formed by Pathway 2a of Scheme 4.
Energy Resolved CID MS/MS in a QuadrupoleTime-of-Flight Mass Spectrometer
The dissociation reactions of the methionine side chain fixed charge sulfonium ion peptide derivatives described above have been further examined by energy resolved CID in a quadrupole-time-of-flight (Q-TOF) mass spectrometer. The energy resolved CID breakdown and appearance curves for the doubly charged sulfonium ion derivative of GAILMGAILK are shown in°Figure°7.°The°breakdown°curve°of°the°precursor°[M ϩ ϩ H] 2ϩ ion, the appearance/breakdown curve of the initial neutral loss product ion (ϪCH 3 SAP), as well as the appearance curves of the individual product ions and that of the summed product ion abundances (sum of°product°ions)°are°indicated°in°Figure°7a.°It°can°be seen that there is essentially no overlap between the breakdown of the [M ϩ ϩ H] 2ϩ ion and the appearance of the individual product ions, indicating that these ions are not formed directly from the initial precursor. Rather, these ions are formed from the initial neutral loss product ion (ϪCH 3 SAP). Given that there was essentially no overlap in the collision energies required for Ͼ90% reduction of the fixed charge containing precursor ion abundance and the formation of second generation product ions from the initial side chain neutral loss product ion, automated data-dependent acquisition methods could be readily developed, whereby "low" energy quadrupole CID conditions are employed for the identification of derivatized peptide ions by the selective formation and detection of an neutral loss product ion, followed by "high" energy "pseudo MS 3 " CID conditions to obtain further structural information regarding the peptide sequence.
Representative product ion spectra taken under collision energies sufficient to obtain 70 -90% reduction of the precursor ion (12 eV) and 70 -90% reduction of the initial neutral loss product ion (22 eV) abundances are shown°in°Figure°7b°and°c,°respectively.°The°product°ion spectra observed under these "low" and "high" energy quadrupole CID conditions, respectively, are essentially identical to those observed by quadrupole ion trap mass spectrometry MS/MS and MS 3 experiments, indicating that the time frame (millisecond versus microsecond time scales for the ion trap and quadrupole experiments, respectively) and mode of ion activation had no appreciable effect on the fragmentation behavior. Indeed, all of the peptides examined under these "low" and "high" energy quadrupole CID conditions exhibited very similar product ion spectra compared to the equivalent ion trap derived MS/MS and MS 3 spectra.
Identification of Methionine Containing Peptides in a Triple Quadrupole Mass Spectrometer by Neutral Loss Scan Code CID MS/MS of Their Sulfonium Ion Fixed-Charge Derivatives
In order to demonstrate the selectivity of the fixed charge derivatization and tandem mass spectrometry approach for the identification of sulfonium ion con- 
taining peptides, 100 pmol of the 66 kDa protein bovine serum albumin was reduced and S-carboxyamidomethylated under basic pH conditions, then subjected to proteolytic digestion using trypsin. The resultant peptide mixture then reacted under acidic conditions with phenacylbromide to yield the side chain sulfonium ion derivatives of methionine containing peptides within the mixture. Ten pmol of this reduced, S-carboxyamidomethylated and sulfonium ion derivatized tryptic peptide mixture was then subjected to on-line capillary RP-HPLC ESI MS using a triple quadrupole mass spectrometer. The total ion current trace obtained from°this°analysis°is°shown°in°Figure°8a.°Several°hun-dred multiply charged ions, corresponding to approximately 100 peptides, were observed by analysis of the individual spectra acquired throughout the chromatographic separation. In the absence of any a priori knowledge regarding the protein sequence however, identification of the sulfonium ion derivatized peptide ions from these mass spectra would not be readily achieved.
Analysis of the same peptide mixture was carried out by on-line capillary RP-HPLC and using a neutral loss scan mode CID MS/MS experiment, to reveal those peptides giving rise to the loss of 83 Th, i.e., the loss of CH 3 SCH 2 COC 6 H 5 , 166 Da from doubly charged methionine side chain sulfonium ion containing precursor ions. The total ion current obtained from this experiment°is°shown°in°Figure°9a.°Four°peaks°were°observed. The mass spectra of the most abundant and least abundant°of°these°four°peaks°are°shown°in°Figure°9b and c. The masses of the major ions present in these four peaks were found to closely correspond to those calculated for tryptic peptides containing each of the four methionine residues within the bovine serum albumin amino°acid°sequence.°The°mass°spectra°shown°in°Figure 8b°and°c,°corresponding°to°the°two°regions°of°the°total ion current chromatogram shown by arrows in the MS experiment, indicate that the ions detected in the neutral°loss°scan°mode°experiment°in°Figure°9b°and°c°are present at relatively low abundance (the ion at m/z 799.4 in°Figure°9b°is°only°the°eighth°most°abundant°ion°in Figure°8b,°and°the°ion°at°m/z 759.8°in°Figure°9c°is°only the°third°most°abundant°ion°in°Figure°9c).
Differential Quantitative Analysis by Neutral Loss Scan Mode CID MS/MS of Stable Isotope Labeled Fixed-Charge Containing Peptide Derivatives in a Triple Quadrupole Mass Spectrometer
The potential for extending the sulfonium ion derivatization approach toward the quantitation of differential protein expression between two peptide samples of interest has been examined by differential stable isotope labeling and neutral loss scan mode MS/MS in a triple quadrupole mass spectrometer. The synthetic peptide GAIMGAILR was derivatized with either a "light" phenacylbromide reagent containing only naturally abundant isotopes ( 1 H 5 -phenacylbromide) or a "heavy" phenacylbromide reagent containing five deuterium isotopes (2=,3=,4=,5=,6=-2 H 5 -phenacylbromide). A nominal 1.0 pmol/L : 1.0 pmol/L mixture of the two derivatized samples was then subjected to MS and neutral loss scan mode MS/MS analysis. By measurement of the peak intensities from the intact precursor ions°observed°in°the°mass spectrum°shown°in°Figure 10a,°a ratio of 1.04:1 can be determined for the doubly A particular advantage of the MS/MS method for differential quantitative analysis described here, over those involving analysis by MS peak abundances alone, is that both ions (i.e., light and heavy labeled forms) are not required to be present in order for detection of one of the pairs, and its origin (i.e., from the "light" or "heavy" sample), to be obtained. Thus, quantitation of peptide ions that are significantly over-or underexpressed compared with a control may still be achieved. Also, given that a common product is formed by neutral loss from both "light" and "heavy" labeled ions, either product may be selected for further structural analysis by "high" energy pseudo CID or MS 3 . One pmol each of the light and heavy derivatized GAILMGAILR peptides were then combined and subjected to capillary RP-HPLC MS analysis. The resultant total ion current trace for this experiment is shown in significantly greater sensitivity than MS methods for differential quantitative analysis. The approach could also by readily applied to the "absolute" quantitative analysis of protein expression, in an analogous manner to recent reports whereby a known quantity of an isotopically encoded peptide of interest is "spiked" into a°sample°of°interest°as°an°internal°standard° [101] .
Less than 10% separation of the 1 H 5 -and 2 H 5 forms of the fixed charge sulfonium ion derivatives across the chromatographic°peaks°in°Figure°12°was°observed, indicating that there is not a strong deuterium isotope effect on the chromatographic fractionation of these fixed charge derivatives. This is consistent with recent reports describing the factors controlling deuterium isotope°effects°on°chromatography° [35,°36] .°In°future work, however, replacement of 2 H with 13 C within the "heavy" derivatization reagent will ensure that light and heavy isotopic variants coelute upon HPLC fractionation, thereby allowing more accurate quantitation without the need for signal averaging across an entire chromatographic peak. For future applications involving the analysis of methionine sulfonium ion containing peptides from complex biologically derived mixtures, the fixed charge derivatives could be pre-enriched by a range of methods prior to mass spectrometry analysis, including°diagonal°chromatography° [102] ,°strong°cation exchange° [76,°103] ,°or°solid°phase°capture° [77] ,°thereby simplifying the mixture complexity and minimizing the potential for m/z overlap between unlabeled and labeled peptide ions. However, either of the two later approaches is preferred because of the ability to obtain direct enrichment of labeled peptides without requirement for separate chromatographic analysis of both unmodified and modified samples.
Conclusions
This study describes a novel strategy for the selective identification of methionine containing peptides and proteins via the formation of side chain "fixed-charge" sulfonium ion derivatives. These sulfonium ions undergo exclusive loss of the derivatized methionine side chain upon CID MS/MS, with concomitant formation of a single characteristic product ion, independent of charge state or amino acid composition. Further structural interrogation of identified peptide ions is achieved by subjecting the characteristic MS/MS product ion to multistage MS/MS (MS 3 ) in a quadrupole ion trap mass spectrometer, or by energy resolved "pseudo" MS 3 in a triple quadrupole mass spectrometer. While the side chain fixed charge derivatization approach has been demonstrated here for a specific amino acid (methionine) and derivatization reaction (sulfonium ions), in principle this approach should be readily applicable to other types of amino acid residues and derivatization reactions. 
